towards improved death receptor targeted therapy for ... - TI Pharma
towards improved death receptor targeted therapy for ... - TI Pharma
towards improved death receptor targeted therapy for ... - TI Pharma
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Contents<br />
Chapter 1 General Introduction and Outline of the thesis 9<br />
Chapter 2 Non-canonical kinase signaling by the <strong>death</strong> ligand<br />
TRAIL in cancer cells: discord in the <strong>death</strong> <strong>receptor</strong><br />
family 15<br />
Chapter 3 MAPK p38 and JNK have opposing activities on<br />
TRAIL-induced apoptosis activation in NSCLC cells<br />
that involves RIP1 and caspase-8 and is mediated<br />
by Mcl-1 39<br />
Chapter 4 Kinome profiling of non-canonical TRAIL signaling<br />
reveals RIP1-Src-STAT3 dependent invasion in<br />
resistant non-small cell lung cancer cells 59<br />
Chapter 5 Inhibition of Hsp90 by 17-AAG enhances TRAILinduced<br />
apoptosis in non-small cell lung cancer cells 83<br />
Chapter 6 The novel thymidylate synthase inhibitor<br />
Trifluorothymidine (TFT) and TRAIL synergistically<br />
eradicate non-small cell lung cancer cells 99<br />
Chapter 7 Accumulation of thymidine-derived sugars in<br />
thymidine phosphorylase overexpressing cells 117<br />
Chapter 8 Summarizing discussion and future perspectives 135<br />
Chapter 9 Summary in Dutch – Nederlandse Samenvatting 145<br />
Acknowledgements – Dankwoord 151<br />
Curriculum vitae 155<br />
‐ 7 ‐